CXCL8 and malignant colon neoplasm: As shown in Figure 4C and Figure S2B, CyCl treatment suppressed the expression of NF-κB target genes, such as NF-κB inhibitor α and δ, TNF-α, IL-6, and IL-8, in TNF-α treated colon cancer cells.